Evidence map›Paper›PMID 25105026›Full record

ReviewNeurology research international2014

Meditation as an adjunct to the management of multiple sclerosis.

Adam B Levin, Emily J Hadgkiss, Tracey J Weiland, George A Jelinek

Abstract readReview
In one paragraph

Review in Neurology research international, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Psychological well-being in people with multiple sclerosis: a descriptive review of the effects obtained with mindfulness interventions.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
    Review
  6. Article
  7. CommunityJournal of alternative and complementary medicine (New York, N.Y.) · 2021
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Adam B LevinDepartment of Medicine, The University of Melbourne, St Vincent's Hospital, Melbourne, VIC 3065, Australia.
Emily J HadgkissEmergency Practice Innovation Centre, St Vincent's Hospital, Melbourne, VIC 3065, Australia.
Tracey J WeilandDepartment of Medicine, The University of Melbourne, St Vincent's Hospital, Melbourne, VIC 3065, Australia ; Emergency Practice Innovation Centre, St Vincent's Hospital, Melbourne, VIC 3065, Australia.
George A JelinekEmergency Practice Innovation Centre, St Vincent's Hospital, Melbourne, VIC 3065, Australia ; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC 3004, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background. Multiple sclerosis (MS) disease course is known to be adversely affected by several factors including stress. A proposed mechanism for decreasing stress and therefore decreasing MS morbidity and improving quality of life is meditation. This review aims to critically analyse the current literature regarding meditation and MS. Methods. Four major databases were used to search for English language papers published before March 2014 with the terms MS, multiple sclerosis, meditation, and mindfulness. Results. 12 pieces of primary literature fitting the selection criteria were selected: two were randomised controlled studies, four were cohort studies, and six were surveys. The current literature varies in quality; however common positive effects of meditation include improved quality of life (QOL) and improved coping skills. Conclusion. All studies suggest possible benefit to the use of meditation as an adjunct to the management of multiple sclerosis. Additional rigorous clinical trials are required to validate the existing findings and determine if meditation has an impact on disease course over time.

Identifiers

PMID25105026
PMCPMC4102064

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.